Canaccord Genuity analyst Michael Graham reiterated a Buy rating on Trupanion (TRUP) on November 8 and set a price target of $43. The company’s shares opened today at $24.89, close to its 52-week low of $22.55.
According to TipRanks.com, Graham is a top 100 analyst with an average return of 16.4% and a 57.4% success rate. Graham covers the Technology sector, focusing on stocks such as Paypal Holdings, Alphabet Inc, and Facebook.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Trupanion with a $41.67 average price target.
The company has a one-year high of $46.70 and a one-year low of $22.55. Currently, Trupanion has an average volume of 493.2K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Trupanion, Inc. engages in the provision of medical insurance for cats and dogs. It operates through the Subscription Business and Other Business segments. The Subscription Business segment involves in the monthly subscriptions of pet medical insurance.